Headlines

Motley Rice has again been selected to The National Law Journal's Plaintiffs' Hot List, highlighting the firm’s work in environmental and securities fraud litigation. The firm, one of 12 firms across the nation receiving the accolade in 2014, was featured in The National.

At approximately 2:40 a.m. (UTC) on Saturday, March 8, 2014, Malaysia Airlines Flight MH370 lost contact with the Subang Air Traffic Control. The flight departed from Kuala Lumpur, the capital of Malaysia, and was in route to Beijing, China.

On March 6, 2014, the United States Fourth Circuit Court of Appeals overturned the district court’s dismissal of hundreds of soldier’s claims against KBR and held that the claims in In re KBR Inc. Burn Pit Litigation may now proceed.

On Monday, March 3, 2014, the U.S. Appeals Court for the Fifth Circuit rejected BP’s request to stop payments for business economic loss claims.

On Thursday, Feb. 27, 2014, Federal Judge David Cercone ruled that primary expert testimony may proceed in the upcoming trial for the lawsuit alleging harmful radioactive emissions in Western Pennsylvania's Parks Township-Apollo area.

BP has created a ticker for its State of The Gulf website entitled “Fraud Tally for Gulf Oil Spill Claims.” This ticker is visible on the home page of the website, which I believe was created by its aggressive and defensive PR machine to skirt paying the people of the Gulf for their grievances related to the 2010 disaster.

Medications carry important risks that the public needs to be warned about up front. We believe the public wants to know more about the serious risks of pharmaceutical drugs and less about the more common side effects.

In the significant <em> Lance v. Wyeth</em> decision, the Pennsylvania Supreme Court rejected Wyeth Ltd.’s argument that it was untouchable for injuries to users of its now discontinued weight loss drug, Redux.

The AAJ is hosting a memorial service in honor of Motley on Monday, Feb. 10, 2014 during its 2014 AAJ Winter Convention in New Orleans.

Plaintiffs lawyers representing thousands of women suing related to the birth control product NuvaRing announced that a settlement was reached with Merck & Co. (MRK:US) on Feb. 7, 2014.